| Primary |
| Asthma |
28.6% |
| Cardiac Failure |
28.6% |
| Diabetes Mellitus |
14.3% |
| Hypertension |
14.3% |
| Insomnia |
14.3% |
|
| Hyponatraemia |
50.0% |
| Torsade De Pointes |
50.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.0% |
| Hypertension |
27.2% |
| Product Used For Unknown Indication |
8.3% |
| Diabetes Mellitus |
5.6% |
| Essential Hypertension |
4.7% |
| Type 2 Diabetes Mellitus |
4.1% |
| Upper Aerodigestive Tract Infection |
4.1% |
| Atrial Fibrillation |
2.1% |
| Anxiety |
1.8% |
| Gout |
1.8% |
| Asthma |
1.5% |
| Back Pain |
1.5% |
| Pain |
1.5% |
| Arteritis |
1.2% |
| Cardiac Failure |
1.2% |
| Insomnia |
1.2% |
| Angina Pectoris |
0.9% |
| Depression |
0.9% |
| Oedema Peripheral |
0.9% |
| Alcoholism |
0.6% |
|
| Renal Failure Acute |
22.5% |
| Hypoglycaemia |
8.8% |
| Vomiting |
8.8% |
| Hyperkalaemia |
7.5% |
| Orthostatic Hypotension |
7.5% |
| Renal Failure |
6.3% |
| Confusional State |
5.0% |
| Wound |
5.0% |
| Hyponatraemia |
3.8% |
| Anaemia |
2.5% |
| Dermatitis Exfoliative |
2.5% |
| Intraventricular Haemorrhage |
2.5% |
| Lung Disorder |
2.5% |
| Malaise |
2.5% |
| Metabolic Acidosis |
2.5% |
| Pemphigoid |
2.5% |
| Urinary Tract Infection |
2.5% |
| Weight Increased |
2.5% |
| Ascites |
1.3% |
| Blood Creatinine Increased |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.7% |
| Drug Use For Unknown Indication |
21.4% |
| Hypertension |
9.7% |
| Type 2 Diabetes Mellitus |
4.3% |
| Breast Cancer |
4.0% |
| Depression |
3.7% |
| Osteoporosis |
3.7% |
| Dementia Alzheimer's Type |
3.4% |
| Diabetes Mellitus |
3.4% |
| Hyperlipidaemia |
3.4% |
| Ill-defined Disorder |
3.4% |
| Hypothyroidism |
2.9% |
| Thrombosis Prophylaxis |
2.6% |
| Essential Hypertension |
2.0% |
| Acute Myeloid Leukaemia |
1.7% |
| Acute Myeloid Leukemia |
1.7% |
| Agitation |
1.7% |
| Hepatic Neoplasm Malignant |
1.7% |
| Meningitis Aseptic |
1.7% |
| Prophylaxis |
1.7% |
|
| Renal Failure Acute |
8.2% |
| Respiratory Distress |
8.2% |
| Cardiac Valve Disease |
6.8% |
| Renal Failure |
6.8% |
| Thrombocytopenia |
6.8% |
| Gastrointestinal Obstruction |
5.5% |
| Sleep Apnoea Syndrome |
5.5% |
| Spontaneous Haematoma |
5.5% |
| Bartholin's Abscess |
4.1% |
| Cholecystitis |
4.1% |
| Confusional State |
4.1% |
| Fixed Eruption |
4.1% |
| Hypoglycaemia |
4.1% |
| Jaundice |
4.1% |
| Pyrexia |
4.1% |
| Somnolence |
4.1% |
| Transaminases Increased |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Angioedema |
2.7% |
| Cardiomyopathy |
2.7% |
|
| Interacting |
| Hypertension |
39.3% |
| Type 2 Diabetes Mellitus |
14.3% |
| Asthma |
7.1% |
| Cardiac Failure |
7.1% |
| Pain |
7.1% |
| Product Used For Unknown Indication |
7.1% |
| Back Pain |
3.6% |
| Diabetes Mellitus |
3.6% |
| Gout |
3.6% |
| Insomnia |
3.6% |
| Thrombosis Prophylaxis |
3.6% |
|
| Renal Failure |
33.3% |
| Cardiac Arrest |
16.7% |
| Drug Interaction |
16.7% |
| Torsade De Pointes |
16.7% |
| Vomiting |
16.7% |
|
